Antiproliferative effect of selexipag active metabolite MRE‐269 on pulmonary arterial smooth muscle cells from patients with chronic thromboembolic pulmonary hypertension

Abstract Chronic thromboembolic pulmonary hypertension (CTEPH) is a group 4 pulmonary hypertension (PH) characterized by nonresolving thromboembolism in the central pulmonary artery and vascular occlusion in the proximal and distal pulmonary artery. Medical therapy is chosen for patients who are ine...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Kazuya Kuramoto, Aiko Ogawa, Kazuko Kiyama, Hiromi Matsubara, Yuji Ohno, Chiaki Fuchikami, Kyota Hayashi, Keiji Kosugi, Keiichi Kuwano
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wiley 2023-04-01
סדרה:	Pulmonary Circulation
נושאים:	CTEPH ID1 PASMC prostacyclin
גישה מקוונת:	https://doi.org/10.1002/pul2.12231
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!